Chemical Stem Cell Signature Predicts Respond To Chemotherapy For Acute ... Jewish Business News ... trials, the signature would help physicians better identify which AML patients would benefit from chemotherapy and which patients have a prognosis so grave that they may be candidates for more aggressive treatments such as bone-marrow transplantation. |
